BRIEF-Mainz Biomed Forms Agreement With Quest Diagnostics To Provide Clinical Trials Laboratory Services For Colorectal Cancer Screening Test

Reuters12-19

Dec 19 (Reuters) - Mainz Biomed NV 4TO.F:

MAINZ BIOMED FORMS AGREEMENT WITH QUEST DIAGNOSTICS TO PROVIDE CLINICAL TRIALS LABORATORY SERVICES FOR COLORECTAL CANCER SCREENING TEST
QUEST TO PROVIDE LAB SERVICES FOR MAINZ BIOMED'S RECONAASENSE STUDY

Source text: ID:nGNXbdy9rL

Further company coverage: 4TO.F

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492617638?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-19 22:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492617638","market":"us","top_or_hot":-1,"title":"BRIEF-Mainz Biomed Forms Agreement With Quest Diagnostics To Provide Clinical Trials Laboratory Services For Colorectal Cancer Screening Test","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Mainz Biomed Forms Agreement With Quest Diagnostics To Provide Clinical Trials Laboratory Services For Colorectal Cancer Screening Test</title></head><body><p><span>Dec 19 (Reuters)</span><span> - </span>Mainz Biomed NV <span>4TO.F</span>:</p><ul><li><p>MAINZ BIOMED FORMS AGREEMENT WITH QUEST DIAGNOSTICS TO PROVIDE CLINICAL TRIALS LABORATORY SERVICES FOR COLORECTAL CANCER SCREENING TEST</p></li><li><p>QUEST TO PROVIDE LAB SERVICES FOR MAINZ BIOMED'S RECONAASENSE STUDY</p></li></ul><p>Source text: <span>ID:nGNXbdy9rL</span></p><p>Further company coverage: <span>4TO.F</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Mainz Biomed Forms Agreement With Quest Diagnostics To Provide Clinical Trials Laboratory Services For Colorectal Cancer Screening Test</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Mainz Biomed Forms Agreement With Quest Diagnostics To Provide Clinical Trials Laboratory Services For Colorectal Cancer Screening Test\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-19 22:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA17NXKB:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Mainz Biomed Forms Agreement With Quest Diagnostics To Provide Clinical Trials Laboratory Services For Colorectal Cancer Screening TestDec 19 (Reuters) - Mainz Biomed NV 4TO.F:MAINZ BIOMED FORMS...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA17NXKB:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4583","symbol_name":"猴痘概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA17NXKB:1","article_id":"2492617638","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492617638","pubTimestamp":1734617511,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Mainz Biomed Forms Agreement With Quest Diagnostics To Provide Clinical Trials Laboratory Services For Colorectal Cancer Screening TestDec 19 (Reuters) - Mainz Biomed NV 4TO.F:MAINZ BIOMED FORMS","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4583":"猴痘概念","DGX":"奎斯特诊疗","BK4588":"碎股","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","BK4196":"保健护理服务","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","BK4567":"ESG概念","BK4585":"ETF&股票定投概念"},"translate_title":"简介-Mainz Biomed与Quest Diagnostics达成协议，为结直肠癌筛查测试提供临床试验实验室服务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":0.9},"content_text":"BRIEF-Mainz Biomed Forms Agreement With Quest Diagnostics To Provide Clinical Trials Laboratory Services For Colorectal Cancer Screening TestDec 19 (Reuters) - Mainz Biomed NV 4TO.F:MAINZ BIOMED FORMS AGREEMENT WITH QUEST DIAGNOSTICS TO PROVIDE CLINICAL TRIALS LABORATORY SERVICES FOR COLORECTAL CANCER SCREENING TESTQUEST TO PROVIDE LAB SERVICES FOR MAINZ BIOMED'S RECONAASENSE STUDYSource text: ID:nGNXbdy9rLFurther company coverage: 4TO.F ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492617638"}